48 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
23 Jun 23
House Lease Contract
4:31pm
month in advance.
Article 10 Special provisions
10.1. Party B shall not give any property, kickback or other improper benefits to Party A’s employees
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
5 Jun 23
Current report (foreign)
4:28pm
financial condition, results of operations, business strategy and plans, prospective products and their potential benefits, product approvals … of CBP-201 compared to dupilumab or of the relative efficacy or safety of icanbelimod compared to Etrasimod or Ozanimod. The potential benefits of CBP-201
F-3/A
ynm mngtn6surff
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
6-K
EX-99.1
cn8m 64wgzcz
10 Jun 22
Current report (foreign)
6:05am
F-3/A
36ihm6b
20 May 22
Shelf registration (foreign) (amended)
6:54pm
6-K
EX-99.2
5oz63078 c6v
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
F-3
2st8n6k
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
EX-1.2
gtatqtf u7a
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-4.12
ww3r126g 20ia8dz
31 Mar 22
Annual report (foreign)
4:33pm
20-F
ls24pfuv957nduz
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
dntfzi 2hcqmb5nz
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
prrt0q f54ss2
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
z1s t75r52
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.2
zahywz6
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.1
xm5aipy3 h2a
5 Jan 22
Current report (foreign)
5:24pm
6-K
EX-99.1
qapbt
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
S-8
EX-4.3
voj8 1xkf2vet0794xp4
19 Mar 21
Registration of securities for employees
5:13pm